Heron Therapeutics, Inc.HRTXNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, structural decline.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-5.06M
↑ 97% above average
Average (9y)
$-155.68M
Historical baseline
Range
High:$-5.06M
Low:$-222.53M
CAGR
-27.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-5.06M | +95.1% |
| 2023 | $-103.79M | +41.2% |
| 2022 | $-176.66M | +17.9% |
| 2021 | $-215.25M | +3.3% |
| 2020 | $-222.53M | -10.6% |
| 2019 | $-201.23M | -15.2% |
| 2018 | $-174.66M | +9.0% |
| 2017 | $-192.02M | -13.4% |
| 2016 | $-169.38M | -76.1% |
| 2015 | $-96.19M | - |